Please provide your email address to receive an email when new articles are posted on . Researchers examined the effects of a remote neuromodulation device in patients with migraine. At 2 hours, pain ...

MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...

Even with the promise of multiple vaccines and eventual reopenings, the COVID-19 pandemic has made the value of telehealth clear, and it’s here to stay. Now, Abbott is launching a virtual clinic that ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the most frequently used neuromodulation device for migraine among ...

Please provide your email address to receive an email when new articles are posted on . CVRx announced it has launched a next-generation version of its ...

The global neuromodulation devices market is poised to witness substantial growth, projected to expand at a CAGR of 9–11% over the next five years. This growth is primarily driven by the increasing ...

The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. According to Grand View Research, the market ...

LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world. Considering the geographic diversification of the business ...

Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations ...